Clinical trial
Positron Emission Tomography Scanning and Epstein-Barr Virus DNA Levels in the…
NCT00188253 · University Health Network, Toronto, Other · Completed
Key facts
| NCT number | NCT00188253 |
|---|---|
| Title | Positron Emission Tomography Scanning and Epstein-Barr Virus DNA Levels in the Staging and Follow-up of Nasopharyngeal Carcinoma. |
| Official title | Positron Emission Tomography Scanning and Epstein-Barr Virus DNA Levels in the Staging and Follow-up of Nasopharyngeal Carcinoma. |
| Lead sponsor | University Health Network, Toronto, Other |
| Status | Completed |
| Study type | Observational |
| Conditions | Nasopharyngeal Carcinoma |
| Enrollment | 30 |
| Start date | Mar 1, 2005 |
| Primary completion | Feb 1, 2017 |
| Completion | Feb 1, 2017 |
| First posted | Sep 16, 2005 |
| Last update posted | Oct 18, 2022 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: